Acurx Pharmaceuticals(ACXP)
$1.03-0.01 (-0.96%)
ACXP
Acurx Pharmaceuticals earnings date
$1.03
At close:-0.01 (-0.96%)
Want to see ACXP full AI Analyst Report?
Acurx Pharmaceuticals (ACXP) Q2 2023 Earnings Report
385 Followers
ACXP Q2 2023 EPS Results
- Actual EPS
- -$5.60
- Consensus EPS
- -$4.67
- Beat/Miss
- Missed by -$0.93
- One Year Ago EPS
- -$5.20
ACXP Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- Before Open
- Conference Call
- Monday, August 14, 2023
ACXP Upcoming Earnings
Acurx Pharmaceuticals's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
ACXP Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
ACXP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | -0.36- | -0.73 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.38-0.49 | -1.23 | 60.16% (+0.74) | |
| Aug 14, 2026 | 2026 (Q2) | -0.38-0.53 | -1.89 | 71.96% (+1.36) | |
| May 12, 2026 | 2026 (Q1) | -1.20-0.62 | -2.2 | 71.82% (+1.58) | |
| Mar 13, 2026 | 2025 (Q4) | -1.01-0.73 | -3.2 | 77.19% (+2.47) | |
| Nov 12, 2025 | 2025 (Q3) | -1.31-1.23 | -3.4 | 63.82% (+2.17) | |
| Aug 12, 2025 | 2025 (Q2) | -2.33-1.89 | -5.2 | 63.65% (+3.31) | |
| May 13, 2025 | 2025 (Q1) | -2.60-2.20 | -5.6 | 60.71% (+3.40) | |
| Mar 18, 2025 | 2024 (Q4) | -3.50-3.20 | -7.4 | 56.76% (+4.20) | |
| Nov 13, 2024 | 2024 (Q3) | -2.90-3.40 | -4.8 | 29.17% (+1.40) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
